Keith Klugman is director for pneumonia at the Bill & Melinda Gates Foundation, where he leads efforts to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools. An expert on antibiotic resistance in pneumonia pathogens and helped develop the pneumococcal vaccine, Klugman has long academic experience and has also worked for the World Health Organization and the U.S. Centers for Disease Control and Prevention.
